Johnson & Johnson Consumer Inc. (J&JCI)

Works in Dermatology · ENT · Genetic & rare · Immunology · Infectious disease · Respiratory

Johnson & Johnson Consumer Inc. (J&JCI) is a clinical trial sponsor. It has no active clinical trials as lead sponsor; its trials since 2021 were across 6 therapeutic areas. Since 2021 it has completed 38 trials and stopped 4 early.

Trial track record · since 2021

0Active trials0 planned participants
38Completed5 with results posted
4Stopped early10% of finished trials

Pipeline · 0 active trials

No active trials with this company as lead sponsor.

Questions about Johnson & Johnson Consumer Inc. (J&JCI)

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-03.

Approve Suite is not affiliated with Johnson & Johnson Consumer Inc. (J&JCI).

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.